The ability of retroviral vector integration to initiate clonal expansion resulting in patient leukaemias with insertions at a subset of integration hotspots (LMO2, BMI1, CCND2) in gene therapy trials indicates the translational relevance of these observations [4,38,39]. The gene discussed is CCND2; the disease is leukemia.